hepatitis a virus gbm strain inactivated

Poland

Drugs containing this active substance

  • AVAXIM 160 IU

    The vaccine is used to immunize adults and adolescents over 16 years of age against hepatitis A virus (HAV).

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    hepatitis a virus gbm strain inactivated 160 antigenic units

    ATC: J07BC02

    Manufacturer: Sanofi Winthrop Industry Sanofi Winthrop Industry Sanofi-Aventis Ltd.